These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 15224198

  • 1. Changes in thymidylate synthase and its inhibition rate and changes in dihydropyrimidine dehydrogenase after the administration of 5-fluorouracil with cisplatin to nude mice with gastric cancer xenograft SC-1-NU.
    Sakurai Y, Uraguchi T, Imazu H, Hasegawa S, Matsubara T, Ochiai M, Funabiki T.
    Gastric Cancer; 2004; 7(2):110-6. PubMed ID: 15224198
    [Abstract] [Full Text] [Related]

  • 2. Thymidylate synthase and dihydropyrimidine dehydrogenase are related to histological effects of 5-fluorouracil and cisplatin neoadjuvant chemotherapy for primary gastric cancer patients.
    Fukuda H, Takiguchi N, Koda K, Oda K, Seike K, Miyazaki M.
    Cancer Invest; 2006; 24(3):235-41. PubMed ID: 16809149
    [Abstract] [Full Text] [Related]

  • 3. Changes of gene expression of thymidine phosphorylase, thymidylate synthase, dihydropyrimidine dehydrogenase after the administration of 5'-deoxy-5-fluorouridine, paclitaxel and its combination in human gastric cancer xenografts.
    Sakurai Y, Yoshida I, Kamoshida S, Inaba K, Isogaki J, Komori Y, Uyama I, Tsutsumi Y.
    Anticancer Res; 2008; 28(3A):1593-602. PubMed ID: 18630517
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synergistic effects of docetaxel and S-1 by modulating the expression of metabolic enzymes of 5-fluorouracil in human gastric cancer cell lines.
    Wada Y, Yoshida K, Suzuki T, Mizuiri H, Konishi K, Ukon K, Tanabe K, Sakata Y, Fukushima M.
    Int J Cancer; 2006 Aug 15; 119(4):783-91. PubMed ID: 16557585
    [Abstract] [Full Text] [Related]

  • 7. Superior antitumour activity of S-1 in tumours with a high dihydropyrimidine dehydrogenase activity.
    Fujiwara H, Terashima M, Irinoda T, Takagane A, Abe K, Nakaya T, Yonezawa H, Oyama K, Takahashi M, Saito K, Takechi T, Fukushima M, Shirasaka T.
    Eur J Cancer; 2003 Nov 15; 39(16):2387-94. PubMed ID: 14556932
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antitumor efficacy of sequential treatment with docetaxel and 5-fluorouracil against human oral cancer cells.
    Tamatani T, Ferdous T, Takamaru N, Hara K, Kinouchi M, Kuribayashi N, Ohe G, Uchida D, Nagai H, Fujisawa K, Miyamoto Y.
    Int J Oncol; 2012 Sep 15; 41(3):1148-56. PubMed ID: 22766915
    [Abstract] [Full Text] [Related]

  • 11. Expression of dihydropyrimidine dehydrogenase in cancer cells but not in stromal cells predicts the efficacy of fluorouracil treatment in patients with gastric carcinoma.
    Hisamitsu K, Tsujitani S, Yamaguchi K, Fukuda K, Konishi I, Kaibara N.
    Anticancer Res; 2004 Sep 15; 24(4):2495-501. PubMed ID: 15330204
    [Abstract] [Full Text] [Related]

  • 12. Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves.
    Nishiyama M, Yamamoto W, Park JS, Okamoto R, Hanaoka H, Takano H, Saito N, Matsukawa M, Shirasaka T, Kurihara M.
    Clin Cancer Res; 1999 Sep 15; 5(9):2620-8. PubMed ID: 10499641
    [Abstract] [Full Text] [Related]

  • 13. Influence of chemotherapeutic agents and cytokines on the expression of 5-fluorouracil-associated enzymes in human colon cancer cell lines.
    Miyazaki K, Shibahara T, Sato D, Uchida K, Suzuki H, Matsui H, Yanaka A, Nakahara A, Matsuzaki Y.
    J Gastroenterol; 2006 Feb 15; 41(2):140-50. PubMed ID: 16568373
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C.
    Oncology; 2006 Feb 15; 70(5):366-77. PubMed ID: 17179731
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The prognostic significance of thymidylate synthase and dihydropyrimidine dehydrogenase in colorectal cancer of 303 patients adjuvantly treated with 5-fluorouracil.
    Jensen SA, Vainer B, Sørensen JB.
    Int J Cancer; 2007 Feb 01; 120(3):694-701. PubMed ID: 17096352
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.